$184.63
00.00%
Pre-Market: Jul 19, 4:03 PM EDT
15 minutes delayed
Comments
Loading...
WEX
WEXNYSE
Unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
WEX (NYSE:WEX) Stock, Analyst Ratings, Price Targets, Forecasts
WEX Inc has a consensus price target of $226.4 based on the ratings of 20 analysts. The high is $285 issued by Baird on April 15, 2024. The low is $180 issued by B of A Securities on October 20, 2022. The 3 most-recent analyst ratings were released by JP Morgan, Keefe, Bruyette & Woods, and Wells Fargo on July 12, 2024, July 8, 2024, and June 5, 2024, respectively. With an average price target of $213.33 between JP Morgan, Keefe, Bruyette & Woods, and Wells Fargo, there's an implied 15.55% upside for WEX Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
JP Morgan
Keefe, Bruyette & Woods
Wells Fargo
Citigroup
Barclays
1calculated from analyst ratings
Analyst Ratings for WEX
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 07/12/2024 | Buy Now | 13.74% | JP Morgan | Tien-Tsin Huang | $246 → $210 | Maintains | Neutral | Get Alert |
| 07/08/2024 | Buy Now | 24.57% | Keefe, Bruyette & Woods | Sanjay Sakhrani | $275 → $230 | Maintains | Outperform | Get Alert |
| 06/05/2024 | Buy Now | 8.32% | Wells Fargo | — | → $200 | Initiates | → Equal-Weight | Get Alert |
| 04/17/2024 | Buy Now | 51.65% | Citigroup | Ashwin Shirvaikar | $240 → $280 | Maintains | Buy | Get Alert |
| 04/16/2024 | Buy Now | 51.65% | Barclays | Ramsey El-Assal | $255 → $280 | Maintains | Overweight | Get Alert |
| 04/15/2024 | Buy Now | 54.36% | Baird | David Koning | $272 → $285 | Maintains | Outperform | Get Alert |
| 04/12/2024 | Buy Now | 29.99% | Jefferies | Trevor Williams | $235 → $240 | Maintains | Hold | Get Alert |
| 03/26/2024 | Buy Now | 48.95% | Evercore ISI Group | Sheriq Sumar | $250 → $275 | Maintains | Outperform | Get Alert |
| 02/13/2024 | Buy Now | 27.28% | Mizuho | Dan Dolev | $225 → $235 | Maintains | Buy | Get Alert |
| 02/12/2024 | Buy Now | 38.11% | Barclays | Ramsey El-Assal | $240 → $255 | Maintains | Overweight | Get Alert |
| 02/09/2024 | Buy Now | 19.16% | Truist Securities | Andrew Quail | $185 → $220 | Maintains | Hold | Get Alert |
| 02/09/2024 | Buy Now | 29.45% | JP Morgan | Tien-Tsin Huang | $205 → $239 | Maintains | Neutral | Get Alert |
| 01/18/2024 | Buy Now | 21.87% | Mizuho | Dan Dolev | $200 → $225 | Maintains | Buy | Get Alert |
| 10/31/2023 | Buy Now | 8.32% | Mizuho | Dan Dolev | $225 → $200 | Maintains | Buy | Get Alert |
| 10/30/2023 | Buy Now | 21.87% | Barclays | Ramsey El-Assal | $245 → $225 | Maintains | Overweight | Get Alert |
| 10/27/2023 | Buy Now | 8.32% | Morgan Stanley | James Faucette | $205 → $200 | Maintains | Equal-Weight | Get Alert |
| 10/24/2023 | Buy Now | 11.03% | Morgan Stanley | James Faucette | $200 → $205 | Maintains | Equal-Weight | Get Alert |
| 10/17/2023 | Buy Now | 29.99% | Wolfe Research | Darrin Peller | → $240 | Upgrade | Peer Perform → Outperform | Get Alert |
| 10/04/2023 | Buy Now | 29.99% | Citigroup | Ashwin Shirvaikar | $230 → $240 | Maintains | Buy | Get Alert |
| 09/21/2023 | Buy Now | 48.95% | Baird | David Koning | $252 → $275 | Maintains | Outperform | Get Alert |
| 08/22/2023 | Buy Now | 26.2% | JP Morgan | Tien-Tsin Huang | $218 → $233 | Maintains | Neutral | Get Alert |
| 07/28/2023 | Buy Now | 13.74% | Credit Suisse | Nik Cremo | $195 → $210 | Maintains | Neutral | Get Alert |
| 07/07/2023 | Buy Now | 2.91% | Deutsche Bank | Ashish Sabadra | → $190 | Initiates | → Hold | Get Alert |
| 04/28/2023 | Buy Now | 2.91% | Truist Securities | Andrew Quail | $185 → $190 | Maintains | Hold | Get Alert |
| 04/28/2023 | Buy Now | 27.82% | Baird | David Koning | $222 → $236 | Maintains | Outperform | Get Alert |
| 02/13/2023 | Buy Now | 24.57% | Citigroup | Ashwin Shirvaikar | $190 → $230 | Maintains | Buy | Get Alert |
| 02/10/2023 | Buy Now | 19.16% | Mizuho | Dan Dolev | → $200 | Reiterates | → Buy | Get Alert |
| 02/10/2023 | Buy Now | 16.45% | Truist Securities | Andrew Jeffrey | $190 → $215 | Maintains | Hold | Get Alert |
| 02/10/2023 | Buy Now | 7.78% | Morgan Stanley | James Faucette | $157 → $199 | Maintains | Equal-Weight | Get Alert |
| 02/10/2023 | Buy Now | 20.24% | Baird | David Koning | $200 → $222 | Maintains | Outperform | Get Alert |
| 01/25/2023 | Buy Now | 8.32% | Baird | David Koning | $190 → $200 | Maintains | Outperform | Get Alert |
| 01/23/2023 | Buy Now | 13.2% | Barclays | Ramsey El-Assal | $213 → $209 | Maintains | Overweight | Get Alert |
| 01/20/2023 | Buy Now | 2.91% | Truist Securities | Andrew Jeffrey | $170 → $190 | Maintains | Hold | Get Alert |
| 01/09/2023 | Buy Now | 4.53% | Wells Fargo | Jeff Cantwell | $185 → $193 | Maintains | Overweight | Get Alert |
| 11/14/2022 | Buy Now | 8.32% | Mizuho | Dan Dolev | $220 → $200 | Maintains | Buy | Get Alert |
| 10/31/2022 | Buy Now | 15.37% | Barclays | Ramsey El-Assal | $211 → $213 | Maintains | Overweight | Get Alert |
| 10/28/2022 | Buy Now | -14.97% | Morgan Stanley | James Faucette | $148 → $157 | Maintains | Equal-Weight | Get Alert |
| 10/28/2022 | Buy Now | 0.2% | Wells Fargo | Jeff Cantwell | $170 → $185 | Maintains | Overweight | Get Alert |
| 10/20/2022 | Buy Now | -2.51% | B of A Securities | Mihir Bhatia | $225 → $180 | Maintains | Buy | Get Alert |
| 10/13/2022 | Buy Now | -21.46% | Truist Securities | Andrew Jeffrey | $185 → $145 | Maintains | Hold | Get Alert |
| 10/11/2022 | Buy Now | -19.84% | Morgan Stanley | James Faucette | $180 → $148 | Maintains | Equal-Weight | Get Alert |
| 09/15/2022 | Buy Now | 14.28% | Barclays | Ramsey El-Assal | $220 → $211 | Maintains | Overweight | Get Alert |
| 09/08/2022 | Buy Now | 5.08% | Wells Fargo | Jeff Cantwell | $210 → $194 | Maintains | Overweight | Get Alert |
| 08/01/2022 | Buy Now | 19.16% | Mizuho | Dan Dolev | $212 → $220 | Maintains | Buy | Get Alert |
| 08/01/2022 | Buy Now | 19.16% | Barclays | Ramsey El-Assal | $217 → $220 | Maintains | Overweight | Get Alert |
| 08/01/2022 | Buy Now | 5.62% | Credit Suisse | Nik Cremo | $185 → $195 | Maintains | Neutral | Get Alert |
| 07/29/2022 | Buy Now | 0.2% | Truist Securities | Andrew Jeffrey | $170 → $185 | Maintains | Hold | Get Alert |
| 07/27/2022 | Buy Now | 14.82% | Mizuho | Dan Dolev | $235 → $212 | Maintains | Buy | Get Alert |
| 07/19/2022 | Buy Now | 17.53% | Barclays | Ramsey El-Assal | $232 → $217 | Maintains | Overweight | Get Alert |
| 06/09/2022 | Buy Now | 13.74% | Citigroup | Peter Christiansen | $190 → $210 | Upgrade | Neutral → Buy | Get Alert |
| 06/02/2022 | Buy Now | 24.57% | Evercore ISI Group | Sheriq Sumar | → $230 | Assumes | → Outperform | Get Alert |
| 05/02/2022 | Buy Now | 27.28% | Mizuho | Dan Dolev | $220 → $235 | Maintains | Buy | Get Alert |
| 04/29/2022 | Buy Now | 14.82% | Wells Fargo | Jeff Cantwell | $205 → $212 | Maintains | Overweight | Get Alert |
| 04/14/2022 | Buy Now | 25.66% | Barclays | Ramsey El-Assal | $225 → $232 | Maintains | Overweight | Get Alert |
| 04/05/2022 | Buy Now | 11.03% | Wells Fargo | Jeff Cantwell | → $205 | Initiates | → Overweight | Get Alert |
| 02/16/2022 | Buy Now | 19.16% | Mizuho | Dan Dolev | $200 → $220 | Maintains | Buy | Get Alert |
| 02/14/2022 | Buy Now | 5.62% | Credit Suisse | Nik Cremo | $180 → $195 | Maintains | Neutral | Get Alert |
| 01/25/2022 | Buy Now | 8.32% | Mizuho | Dan Dolev | $205 → $200 | Maintains | Buy | Get Alert |
| 11/02/2021 | Buy Now | 11.03% | Mizuho | Dan Dolev | — | Maintains | Buy | Get Alert |
| 11/01/2021 | Buy Now | 13.74% | Barclays | Ramsey El-Assal | — | Maintains | Overweight | Get Alert |
| 10/29/2021 | Buy Now | 5.62% | Credit Suisse | Nik Cremo | — | Maintains | Neutral | Get Alert |
| 10/13/2021 | Buy Now | — | B of A Securities | Mihir Bhatia | — | Upgrade | Neutral → Buy | Get Alert |
| 08/17/2021 | Buy Now | 7.24% | JP Morgan | Tien-Tsin Huang | — | Maintains | Neutral | Get Alert |
| 08/02/2021 | Buy Now | 35.41% | Barclays | Ramsey El-Assal | — | Maintains | Overweight | Get Alert |
| 08/02/2021 | Buy Now | 27.28% | Mizuho | Dan Dolev | — | Maintains | Buy | Get Alert |
| 07/30/2021 | Buy Now | 5.62% | Morgan Stanley | — | — | Maintains | Equal-Weight | Get Alert |
| 07/30/2021 | Buy Now | 29.99% | Cowen & Co. | George Mihalos | — | Maintains | Outperform | Get Alert |
FAQ
What is the target price for WEX (WEX) stock?
The latest price target for WEX (NYSE:WEX) was reported by JP Morgan on July 12, 2024. The analyst firm set a price target for $210.00 expecting WEX to rise to within 12 months (a possible 13.74% upside). 22 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for WEX (WEX)?
The latest analyst rating for WEX (NYSE:WEX) was provided by JP Morgan, and WEX maintained their neutral rating.
When was the last upgrade for WEX (WEX)?
The last upgrade for WEX Inc happened on October 17, 2023 when Wolfe Research raised their price target to $240. Wolfe Research previously had a peer perform for WEX Inc.
When was the last downgrade for WEX (WEX)?
There is no last downgrade for WEX.
When is the next analyst rating going to be posted or updated for WEX (WEX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of WEX, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for WEX was filed on July 12, 2024 so you should expect the next rating to be made available sometime around July 12, 2025.
Is the Analyst Rating WEX (WEX) correct?
While ratings are subjective and will change, the latest WEX (WEX) rating was a maintained with a price target of $246.00 to $210.00. The current price WEX (WEX) is trading at is $184.63, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.